These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33937361)

  • 1. The Incremental Prognostic Value of the Clinical Residual SYNTAX Score for Patients With Chronic Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
    Yan L; Li P; Wang Y; Han D; Li S; Jiang M; Cao X; Cao F
    Front Cardiovasc Med; 2021; 8():647720. PubMed ID: 33937361
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of the residual SYNTAX score on clinical outcomes after percutaneous coronary intervention for patients with chronic renal insufficiency.
    Yan L; Li P; Wang Y; Han D; Li S; Zhang J; Jiang M; Fan L; Han Y; Cao F
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1(Suppl 1):606-615. PubMed ID: 31868307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating the residual SYNTAX score to improve the predictive ability of the age, creatinine, and ejection fraction (ACEF) score for cardiac mortality in percutaneous coronary intervention patients.
    Gao G; Zhang D; Song C; Xu H; Yin D; Guan C; Yang Y; Xu B; Dou K
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():534-541. PubMed ID: 31876352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Objectifying the impact of incomplete revascularization by repeat angiographic risk assessment with the residual SYNTAX score after left main coronary artery percutaneous coronary intervention.
    Capodanno D; Chisari A; Giacoppo D; Bonura S; Lavanco V; Capranzano P; Caggegi A; Ministeri M; Tamburino C
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):333-40. PubMed ID: 22936604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proximal left anterior descending coronary artery stenosis should be considered when using the prognostic value of the residual SYNTAX score: Data from 10343 consecutive patients with long-term follow up in the real world.
    Gao G; Feng L; Zhang D; Song C; Zhu C; Song W; Zhao Y; Xu B; Yin D; Dou K
    Catheter Cardiovasc Interv; 2018 Feb; 91(S1):639-645. PubMed ID: 29542281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of residual SYNTAX score in patients with ST-elevation myocardial infarction and multivessel disease: Analysis of an 8-year all-comers registry.
    Braga CG; Cid-Alvarez AB; Diéguez AR; Alvarez BA; Otero DL; Sánchez RO; Pena XS; Salvado VG; Trillo-Nouche R; González-Juanatey JR
    Int J Cardiol; 2017 Sep; 243():21-26. PubMed ID: 28532984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score.
    Généreux P; Palmerini T; Caixeta A; Rosner G; Green P; Dressler O; Xu K; Parise H; Mehran R; Serruys PW; Stone GW
    J Am Coll Cardiol; 2012 Jun; 59(24):2165-74. PubMed ID: 22483327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of the Residual SYNTAX Score in Patients With Cardiogenic Shock.
    Barthélémy O; Rouanet S; Brugier D; Vignolles N; Bertin B; Zeitouni M; Guedeney P; Hauguel-Moreau M; Hage G; Overtchouk P; Akin I; Desch S; Vicaut E; Zeymer U; Thiele H; Montalescot G
    J Am Coll Cardiol; 2021 Jan; 77(2):144-155. PubMed ID: 33446307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Usefulness of the residual SYNTAX score to predict long term outcome in acute coronary syndrome patients underwent percutaneous coronary intervention].
    Song Y; Xu JJ; Tang XF; Ma YL; Yao Y; He C; Wang HH; Liu R; Xu N; Jiang P; Jiang L; Zhao XY; Gao Z; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(7):502-507. PubMed ID: 28260288
    [No Abstract]   [Full Text] [Related]  

  • 11. Objectifying the level of incomplete revascularization by the residual SYNTAX score and evaluating its impact on the one-year outcome of percutaneous coronary intervention in patients with multi-vessel disease.
    Alidoosti M; Saroukhani S; Lotfi-Tokaldany M; Jalali A; Sobh-Rakhshankhah A
    Cardiovasc Revasc Med; 2016; 17(5):308-12. PubMed ID: 27198530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Value of Incomplete Revascularization after Percutaneous Coronary Intervention Following Acute Coronary Syndrome: Focus on CKD Patients.
    Cardi T; Kayali A; Trimaille A; Marchandot B; Ristorto J; Hoang VA; Hess S; Kibler M; Jesel L; Ohlmann P; Morel O
    J Clin Med; 2019 Jun; 8(6):. PubMed ID: 31174280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of the Residual SYNTAX Score After Functionally Complete Revascularization in ACS.
    Kobayashi Y; Lønborg J; Jong A; Nishi T; De Bruyne B; Høfsten DE; Kelbæk H; Layland J; Nam CW; Pijls NHJ; Tonino PAL; Warnøe J; Oldroyd KG; Berry C; Engstrøm T; Fearon WF;
    J Am Coll Cardiol; 2018 Sep; 72(12):1321-1329. PubMed ID: 30213322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score.
    Farooq V; Serruys PW; Bourantas CV; Zhang Y; Muramatsu T; Feldman T; Holmes DR; Mack M; Morice MC; Ståhle E; Colombo A; de Vries T; Morel MA; Dawkins KD; Kappetein AP; Mohr FW
    Circulation; 2013 Jul; 128(2):141-51. PubMed ID: 23766350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.
    Park KW; Kang J; Kang SH; Ahn HS; Kang HJ; Koo BK; Chae IH; Youn TJ; Oh BH; Park YB; Kandzari D; Kim HS
    Am Heart J; 2014 Mar; 167(3):384-392.e5. PubMed ID: 24576524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.
    Witberg G; Lavi I; Assali A; Vaknin-Assa H; Lev E; Kornowski R
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):3-10. PubMed ID: 25413668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Residual SYNTAX Score and Its Derived Indexes on Clinical Outcomes after Percutaneous Coronary Intervention: Data from a Large Single Center.
    Song Y; Gao Z; Tang XF; Jiang P; Xu JJ; Yao Y; Li JX; Zhao XY; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Chin Med J (Engl); 2018 Jun; 131(12):1390-1396. PubMed ID: 29893355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Value of Residual Coronary Stenoses After Functionally Complete Revascularization.
    Kobayashi Y; Nam CW; Tonino PA; Kimura T; De Bruyne B; Pijls NH; Fearon WF;
    J Am Coll Cardiol; 2016 Apr; 67(14):1701-11. PubMed ID: 27056776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the Residual SYNTAX Score on Outcomes of Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease.
    Loutfi M; Ayad S; Sobhy M
    Clin Med Insights Cardiol; 2016; 10():29-35. PubMed ID: 26997875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of the residual SYNTAX score on in-hospital outcomes in patients undergoing primary percutaneous coronary intervention.
    Khan R; Al-Hawwas M; Hatem R; Azzalini L; Fortier A; Joliecoeur EM; Tanguay JF; Lavoie-L'Allier P; Ly HQ
    Catheter Cardiovasc Interv; 2016 Nov; 88(5):740-747. PubMed ID: 26833916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.